EnVVeno Capex To Revenue vs Cash Per Share Analysis

NVNO Stock

USD 2.79 0.07 2.45%

EnVVeno Medical financial indicator trend analysis is much more than just examining enVVeno Medical Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether enVVeno Medical Corp is a good investment. Please check the relationship between EnVVeno Medical Capex To Revenue and its Cash Per Share accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Capex To Revenue vs Cash Per Share

Capex To Revenue vs Cash Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of enVVeno Medical Corp Capex To Revenue account and Cash Per Share. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between EnVVeno Medical's Capex To Revenue and Cash Per Share is 0.56. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Cash Per Share in the same time period over historical financial statements of enVVeno Medical Corp, assuming nothing else is changed. The correlation between historical values of EnVVeno Medical's Capex To Revenue and Cash Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of enVVeno Medical Corp are associated (or correlated) with its Cash Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Per Share has no effect on the direction of Capex To Revenue i.e., EnVVeno Medical's Capex To Revenue and Cash Per Share go up and down completely randomly.

Correlation Coefficient

0.56

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Cash Per Share

Most indicators from EnVVeno Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into enVVeno Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of the 19th of December 2024, Enterprise Value is likely to grow to about 64.1 M, while Selling General Administrative is likely to drop about 9.4 M.

	2021	2022	2023	2024 (projected)
Interest Expense	18.7K	263K	236.7K	224.9K
Depreciation And Amortization	452.9K	525K	220K	387.0K

Interest Expense Depreciation And Amortization

EnVVeno Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Receivables	Net Tangible Assets	Other Assets
Total Assets		0.12	-0.59	-0.57	0.99	0.87	-0.31	-0.59	-0.9	-0.33	0.59	0.69	-0.3	1.0	0.96	-0.22	0.8	0.95	-0.47	1.0	-0.46	-0.56	-0.34	-0.6	0.98	-0.68
Short Long Term Debt Total	0.12		0.69	0.68	0.02	-0.03	0.09	-0.12	0.12	-0.13	0.16	0.28	0.59	0.11	0.08	0.46	0.09	-0.06	0.67	0.11	0.78	0.23	-0.19	0.16	-0.01	0.43
Other Current Liab	-0.59	0.69		0.99	-0.67	-0.63	0.28	0.32	0.67	0.24	-0.28	-0.26	0.79	-0.59	-0.59	0.6	-0.43	-0.68	0.93	-0.59	0.95	0.61	-0.13	0.46	-0.67	0.79
Total Current Liabilities	-0.57	0.68	0.99		-0.65	-0.64	0.22	0.36	0.63	0.27	-0.32	-0.25	0.79	-0.57	-0.56	0.61	-0.44	-0.64	0.94	-0.57	0.94	0.62	-0.15	0.44	-0.66	0.77
Total Stockholder Equity	0.99	0.02	-0.67	-0.65		0.88	-0.33	-0.59	-0.91	-0.33	0.58	0.65	-0.39	0.99	0.96	-0.32	0.8	0.96	-0.56	0.99	-0.54	-0.62	-0.3	-0.61	0.99	-0.73
Property Plant And Equipment Net	0.87	-0.03	-0.63	-0.64	0.88		-0.19	-0.67	-0.8	-0.13	0.67	0.79	-0.35	0.87	0.8	-0.34	0.82	0.83	-0.56	0.87	-0.57	-0.68	-0.22	-0.68	0.91	-0.77
Current Deferred Revenue	-0.31	0.09	0.28	0.22	-0.33	-0.19		-0.53	0.62	-0.02	0.53	-0.02	0.15	-0.32	-0.55	0.29	-0.09	-0.53	0.28	-0.32	0.2	0.38	0.2	0.39	-0.35	0.42
Net Debt	-0.59	-0.12	0.32	0.36	-0.59	-0.67	-0.53		0.29	0.13	-1.0	-0.55	0.2	-0.59	-0.35	0.14	-0.69	-0.39	0.3	-0.59	0.33	0.37	0.18	0.34	-0.59	0.39
Retained Earnings	-0.9	0.12	0.67	0.63	-0.91	-0.8	0.62	0.29		0.09	-0.27	-0.57	0.31	-0.9	-0.95	0.34	-0.67	-0.99	0.56	-0.9	0.59	0.65	0.38	0.77	-0.93	0.83
Accounts Payable	-0.33	-0.13	0.24	0.27	-0.33	-0.13	-0.02	0.13	0.09		-0.14	0.0	0.46	-0.33	-0.34	0.04	-0.26	-0.18	0.18	-0.33	-0.05	-0.06	-0.31	-0.5	-0.21	-0.23
Cash	0.59	0.16	-0.28	-0.32	0.58	0.67	0.53	-1.0	-0.27	-0.14		0.56	-0.17	0.59	0.34	-0.12	0.69	0.38	-0.26	0.58	-0.28	-0.35	-0.19	-0.32	0.58	-0.36
Non Current Assets Total	0.69	0.28	-0.26	-0.25	0.65	0.79	-0.02	-0.55	-0.57	0.0	0.56		0.17	0.68	0.62	0.22	0.45	0.61	-0.05	0.68	-0.22	-0.21	-0.08	-0.58	0.68	-0.44
Non Currrent Assets Other	-0.3	0.59	0.79	0.79	-0.39	-0.35	0.15	0.2	0.31	0.46	-0.17	0.17		-0.31	-0.3	0.82	-0.4	-0.35	0.89	-0.31	0.66	0.58	-0.28	-0.02	-0.35	0.45
Cash And Short Term Investments	1.0	0.11	-0.59	-0.57	0.99	0.87	-0.32	-0.59	-0.9	-0.33	0.59	0.68	-0.31		0.96	-0.23	0.81	0.95	-0.48	1.0	-0.46	-0.56	-0.35	-0.6	0.98	-0.68
Common Stock Shares Outstanding	0.96	0.08	-0.59	-0.56	0.96	0.8	-0.55	-0.35	-0.95	-0.34	0.34	0.62	-0.3	0.96		-0.21	0.7	0.97	-0.46	0.96	-0.43	-0.52	-0.32	-0.58	0.94	-0.66
Non Current Liabilities Total	-0.22	0.46	0.6	0.61	-0.32	-0.34	0.29	0.14	0.34	0.04	-0.12	0.22	0.82	-0.23	-0.21		-0.41	-0.33	0.85	-0.23	0.58	0.85	-0.11	0.25	-0.33	0.61
Other Current Assets	0.8	0.09	-0.43	-0.44	0.8	0.82	-0.09	-0.69	-0.67	-0.26	0.69	0.45	-0.4	0.81	0.7	-0.41		0.72	-0.46	0.81	-0.33	-0.65	-0.48	-0.42	0.79	-0.56
Other Stockholder Equity	0.95	-0.06	-0.68	-0.64	0.96	0.83	-0.53	-0.39	-0.99	-0.18	0.38	0.61	-0.35	0.95	0.97	-0.33	0.72		-0.57	0.95	-0.58	-0.64	-0.36	-0.72	0.97	-0.8
Total Liab	-0.47	0.67	0.93	0.94	-0.56	-0.56	0.28	0.3	0.56	0.18	-0.26	-0.05	0.89	-0.48	-0.46	0.85	-0.46	-0.57		-0.48	0.89	0.79	-0.15	0.41	-0.58	0.78
Total Current Assets	1.0	0.11	-0.59	-0.57	0.99	0.87	-0.32	-0.59	-0.9	-0.33	0.58	0.68	-0.31	1.0	0.96	-0.23	0.81	0.95	-0.48		-0.46	-0.56	-0.35	-0.6	0.98	-0.68
Short Term Debt	-0.46	0.78	0.95	0.94	-0.54	-0.57	0.2	0.33	0.59	-0.05	-0.28	-0.22	0.66	-0.46	-0.43	0.58	-0.33	-0.58	0.89	-0.46		0.61	-0.05	0.6	-0.59	0.84
Intangible Assets	-0.56	0.23	0.61	0.62	-0.62	-0.68	0.38	0.37	0.65	-0.06	-0.35	-0.21	0.58	-0.56	-0.52	0.85	-0.65	-0.64	0.79	-0.56	0.61		0.1	0.63	-0.66	0.84
Common Stock	-0.34	-0.19	-0.13	-0.15	-0.3	-0.22	0.2	0.18	0.38	-0.31	-0.19	-0.08	-0.28	-0.35	-0.32	-0.11	-0.48	-0.36	-0.15	-0.35	-0.05	0.1		0.42	-0.33	0.23
Net Receivables	-0.6	0.16	0.46	0.44	-0.61	-0.68	0.39	0.34	0.77	-0.5	-0.32	-0.58	-0.02	-0.6	-0.58	0.25	-0.42	-0.72	0.41	-0.6	0.6	0.63	0.42		-0.71	0.88
Net Tangible Assets	0.98	-0.01	-0.67	-0.66	0.99	0.91	-0.35	-0.59	-0.93	-0.21	0.58	0.68	-0.35	0.98	0.94	-0.33	0.79	0.97	-0.58	0.98	-0.59	-0.66	-0.33	-0.71		-0.8
Other Assets	-0.68	0.43	0.79	0.77	-0.73	-0.77	0.42	0.39	0.83	-0.23	-0.36	-0.44	0.45	-0.68	-0.66	0.61	-0.56	-0.8	0.78	-0.68	0.84	0.84	0.23	0.88	-0.8

Click cells to compare fundamentals

EnVVeno Medical Account Relationship Matchups

EnVVeno Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4M	10.5M	57.7M	41.7M	48.6M	51.1M
Other Current Liab	333.4K	1.1M	438.0K	254K	268K	254.6K
Total Current Liabilities	1.9M	3.2M	1.6M	1.5M	1.4M	2.3M
Total Stockholder Equity	989.9K	7.1M	54.4M	38.7M	46.2M	48.5M
Property Plant And Equipment Net	1.2M	938.9K	2.6M	2.2M	1.7M	1.1M
Net Debt	(450.6K)	(8.5M)	(52.7M)	(2.8M)	(2.2M)	(2.3M)
Retained Earnings	(56.2M)	(65.3M)	(81.9M)	(106.5M)	(130.0M)	(123.5M)
Accounts Payable	1.2M	1.4M	560K	648K	427K	705.3K
Cash	1.3M	9.3M	54.7M	4.6M	3.6M	3.4M
Non Current Assets Total	2.0M	968.8K	2.7M	2.2M	1.7M	1.8M
Cash And Short Term Investments	1.3M	9.3M	54.7M	39.0M	46.4M	48.7M
Common Stock Shares Outstanding	630.4K	1.3M	8.7M	11.2M	12.3M	12.9M
Liabilities And Stockholders Equity	3.4M	10.5M	57.7M	41.7M	48.6M	51.1M
Non Current Liabilities Total	567.9K	253.7K	1.7M	1.4M	1.1M	1.5M
Other Current Assets	116.6K	468.9K	624.4K	392K	511K	304.4K
Other Stockholder Equity	57.2M	72.4M	136.3M	145.2M	176.2M	185.0M
Total Liab	2.4M	3.4M	3.3M	2.9M	2.4M	3.7M
Total Current Assets	1.4M	9.6M	55.0M	39.4M	46.9M	49.3M
Short Term Debt	288.7K	626.9K	582.1K	628K	676K	703.2K
Common Stock	117.0	179.0	25.0	95.0	85.5	82.17
Net Tangible Assets	989.9K	7.1M	54.4M	38.7M	44.5M	46.8M
Net Invested Capital	989.9K	7.4M	54.4M	38.7M	46.2M	48.5M
Net Working Capital	(452.4K)	6.4M	53.5M	37.9M	45.6M	47.8M
Property Plant Equipment	1.2M	938.9K	2.6M	521K	599.2K	968.9K

Pair Trading with EnVVeno Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against EnVVeno Stock

0.57	ECOR	Electrocore LLC Upward Rally	Pair Corr
0.55	MD	Mednax Inc	Pair Corr
0.49	VREX	Varex Imaging Corp	Pair Corr
0.48	OM	Outset Medical	Pair Corr
0.44	DOCS	Doximity	Pair Corr

The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.

The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:

How To Invest In EnVVeno

Details

Is EnVVeno Stock a good investment?

Details

What is EnVVeno Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.29)

Return On Assets

(0.37)

Return On Equity

(0.59)

The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

EnVVeno Capex To Revenue vs Cash Per Share Analysis

Capex To Revenue vs Cash Per Share

Capex To Revenue vs Cash Per Share Correlation Analysis

Correlation Coefficient

Capex To Revenue

Cash Per Share

EnVVeno Medical fundamental ratios Correlations

EnVVeno Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

EnVVeno Medical fundamental ratios Accounts

Pair Trading with EnVVeno Medical

Moving against EnVVeno Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.99	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Net Tangible Assets	- 0.93	Retained Earnings
Retained Earnings	- 0.91	Total Stockholder Equity
Total Current Assets	- 0.9	Retained Earnings